HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination

Ceri Evans, MBBCh, Christine E Jones, PhD, Dr Andrew J Prendergast, DPhil

The number of infants infected with HIV is declining with the rise in interventions for the elimination of paediatric HIV infection, but the number of uninfected infants exposed to HIV through their HIV-infected mothers is increasing. Interest in the health outcomes of HIV-exposed, uninfected infants has grown in the past decade, with several studies suggesting that these infants have increased mortality rates, increased infectious morbidity, and impaired growth compared with HIV-unexposed infants. However, heterogeneous results might reflect the inherent challenges in studies of HIV-exposed, uninfected infants, which need large populations with appropriate, contemporaneous comparison groups and repeated HIV testing throughout the period of breastfeeding. We review the effects of HIV exposure on mortality, morbidity, and growth, discuss the immunological abnormalities identified so far, and provide an overview of interventions that could be effective in this susceptible population. As the number of infants infected with HIV declines, the health needs of HIV-exposed, uninfected infants should be prioritised further, to ensure that post-2015 Sustainable Development Goals are achieved.

June 23, 2016
Year of publication
Resource types
Journal and research articles, Reports and Fact sheets
HIV, HIV prevention, paediatric HIV infections, PMTCT, infant mortality, breastfeeding, sustainable development, children, women, research, pediatric HIV, HIV exposed infants

Similar Resources


South Africa (SA) is likely to meet the National Strategic Plan target of

OBJECTIVE: To evaluate the impact of substituting this recommendation for the post-weaning HIV testing recommended by SA guidelines. 

This supplement to Acta Paediatrica presents a series of meta-analyses and systematic literature reviews examining a variety of health effects potentially related to breastfeeding.

Since the late 1990s, by providing services to prevent mother-to-child transmission of HIV, many countries have made significant progress toward eliminating new HIV infections in children.

Lactation studies are necessary evaluations of medications for reproductive-age women. We evaluated pharmacokinetics (PK), pharmacodynamics, safety, and adherence profiles associated with 7 days of 1% tenofovir (TFV) vaginal gel use during lactation.

Objective: This prospective study investigated the relationship between male antenatal clinic (ANC) involvement and infant HIV-free survival.

HIV presents an increasing risk to pregnant women, their infants, and their families.

In guidelines released in 2010, the World Health Organization recommends that health facilities integrate prevention of mother-to-child transmission (PMTCT) with maternal, newborn, and child health (MNCH) services to improve patient follow-up and adherence.

In Zambia’s Southern Province, the Community PMTCT Follow-up Register Project is improving access and adherence to HIV testing and treatment for pregnant women and their children.